Authors: Kotajima, N.; Kanda, T.; Yuuki, N.; Kimura, T.; Kishi, S.; Fukumura, Y.; Tamura, J.; Kobayashi, I.

Source: The Journal of International Medical Research, Volume 29, Number 4, July 2001 , pp. 292-296(5)

Publisher: Field House Publishing

Abstract:

We compared the levels of type IV collagen (IV-C) in vitreous fluid and serum and the levels of glycosylated haemoglobin in 47 patients with proliferative diabetic retinopathy (DR) and 21 patients with non-inflammatory retinopathies. Levels of IV-C were found to be higher in the vitreous fluid in patients with DR than in patients with non-inflammatory retinopathy (53.2 ± 14.9 μg/l versus 14.7 ± 4.5 μg/l). Serum levels were likewise higher in patients with DR (349.7 ± 106.2 μg/l versus 97.7 ± 13.1 μg/l) as were glycosylated haemoglobin levels (8.3 ± 0.3% versus 5.2 ± 0.4%). In addition, levels of type IV collagen in the vitreous fluid were found to be higher in the patients who had been diabetic for ≥ 10 years than in patients who had been diabetic for < 10 years (54.8 ± 15.5 μg/l versus 16.8 ± 4.6 μg/l). We conclude that accumulation of vitreous fluid IV-C may relate to high levels of glycosylated haemoglobin and long duration of diabetes. This suggests that the concentration of IV-C in vitreous fluid, and possibly also the serum levels of IV-C, reflects the progression of DR. Further investigation is needed to verify this and to investigate whether or not measuring IV-C levels is a useful means to assess therapeutic effects and/or prognosis of diabetic microangiopathy.

Articles that cite this article?

Keywords: DIABETIC RETINOPATHY; TYPE IV COLLAGEN; VITREOUS FLUID

Document Type: Research article

Publication date: 2001-07-01

More about this publication?

• The Journal of International Medical Research (JIMR) is a leading peer reviewed journal offering exceptional publication speed for medical, clinical and pre-clinical research. Reviews, case studies, preliminary communications, post-marketing surveillance, pharmacoeconomic and managed care studies are also welcome. Supplements publish symposium proceedings or collections of medical, pre-clinical or clinical data and enquiries from potential sponsors are welcome. JIMR is widely indexed and abstracted, including Medline, Current Contents and Excerpta Medica (EMBASE).
• Editorial Board
• Information for Authors
• Submit a Paper
• Subscribe to this Title
• Information for Advertisers
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Internal Medicine ,  Pharmacology ,  Public Health
• By this author: Kotajima, N. ;  Kanda, T. ;  Yuuki, N. ;  Kimura, T. ;  Kishi, S. ;  Fukumura, Y. ;  Tamura, J. ;  Kobayashi, I.

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers